205 related articles for article (PubMed ID: 33488018)
1. Intravitreal Triamcinolone Acetonide in Von Hippel-Lindau Patient with Novel Mutation.
Bunajem M; Magliyah M; Alzahrani Y
Middle East Afr J Ophthalmol; 2020; 27(3):188-190. PubMed ID: 33488018
[TBL] [Abstract][Full Text] [Related]
2. Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.
Tsai FY; Lau LI; Chen SJ; Lee FL; Lee SM
J Chin Med Assoc; 2014 Jan; 77(1):52-6. PubMed ID: 24206762
[TBL] [Abstract][Full Text] [Related]
3. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
[TBL] [Abstract][Full Text] [Related]
4. Ocular von Hippel-Lindau disease: clinical update and emerging treatments.
Wong WT; Chew EY
Curr Opin Ophthalmol; 2008 May; 19(3):213-7. PubMed ID: 18408496
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?
Azimi F; Aghajani A; Khakpour G; Chaibakhsh S
Mol Genet Genomics; 2022 Nov; 297(6):1615-1626. PubMed ID: 36006455
[TBL] [Abstract][Full Text] [Related]
6. Unusual ocular presentation of von Hippel-Lindau disease.
Valenzuela A; Druker H; Malkin D; Gallie B; Héon E
Can J Ophthalmol; 2005 Oct; 40(5):593-7. PubMed ID: 16391622
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients.
Lee SH; Park KH; Woo SJ; Park SJ; Joo K
Korean J Ophthalmol; 2022 Dec; 36(6):543-549. PubMed ID: 36281577
[TBL] [Abstract][Full Text] [Related]
8. [Retinal capillary hemangioma and von Hippel-Lindau disease: diagnostic and therapeutic implications].
Salazar R; González-Castaño C; Rozas P; Castro J
Arch Soc Esp Oftalmol; 2011 Jul; 86(7):218-21. PubMed ID: 21798408
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in the management of retinal capillary haemangiomas associated with von Hippel Lindau disease.
Pastor-Montoro M; Hurtado-Montalbán N; Martínez-Morales JA; Villegas-Pérez MP
Arch Soc Esp Oftalmol; 2017 Dec; 92(12):605-608. PubMed ID: 28169069
[TBL] [Abstract][Full Text] [Related]
10. Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease.
Piermarocchi S; Lo Giudice G; Pilotto E; Bertoja E; Scaroni C; Martella M; Opocher G; Murgia A
Graefes Arch Clin Exp Ophthalmol; 2000 Jul; 238(7):615-20. PubMed ID: 10955664
[TBL] [Abstract][Full Text] [Related]
11. Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome.
Murro V; Lippera M; Mucciolo DP; Canu L; Ercolino T; De Filpo G; Giorgio D; Traficante G; Sodi A; Virgili G; Giansanti F
Mol Vis; 2021; 27():542-554. PubMed ID: 34566400
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
Dahr SS; Cusick M; Rodriguez-Coleman H; Srivastava SK; Thompson DJ; Linehan WM; Ferris FL; Chew EY
Retina; 2007 Feb; 27(2):150-8. PubMed ID: 17290195
[TBL] [Abstract][Full Text] [Related]
13. INTRAVITREAL INJECTION OF PROPRANOLOL FOR THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMA IN A CASE OF VON HIPPEL-LINDAU.
Karimi S; Nikkhah H; Ahmadieh H; Safi S
Retin Cases Brief Rep; 2020; 14(4):305-309. PubMed ID: 29466252
[TBL] [Abstract][Full Text] [Related]
14. Clinical Results of Various Treatments for Retinal Capillary Hemangioma.
Won YK; Lee MW; Shin YI; Kim JY; Jo YJ
Korean J Ophthalmol; 2020 Apr; 34(2):133-142. PubMed ID: 32233147
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
[TBL] [Abstract][Full Text] [Related]
16. Massive exudative retinal detachment following photodynamic therapy for retinal hemangioma in von Hippel-Lindau Syndrome.
Chen Y; Liu H; Zhang K; Gao L
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):250-3. PubMed ID: 24632330
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.
Toy BC; Agrón E; Nigam D; Chew EY; Wong WT
Ophthalmology; 2012 Dec; 119(12):2622-30. PubMed ID: 22906772
[TBL] [Abstract][Full Text] [Related]
18. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
19. SPONTANEOUS RESOLUTION OF MACULAR EPIRETINAL MEMBRANES AFTER FLUORESCEIN POTENTIATED ARGON LASER TREATMENT OF VON HIPPEL-LINDAU ASSOCIATED RETINAL HEMANGIOMAS: CASE REPORT AND REVIEW OF LITERATURE.
Kolomeyer AM; Eller AW; Martel JN
Retin Cases Brief Rep; 2016; 10(2):145-50. PubMed ID: 26421964
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.
Wu X; Chen L; Zhang Y; Xie H; Xue M; Wang Y; Huang H
BMC Med Genet; 2018 Nov; 19(1):204. PubMed ID: 30477447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
